Cognitive Changes Related to Cancer Therapy

Research output: Contribution to journalReview articlepeer-review


A growing population of cancer survivors is at risk for acute and long-term consequences resulting from cancer and its treatment. Cancer-related cognitive impairment (CRCI) typically manifests as modest deficits in attention, processing speed, executive functioning, and memory, which may persist for decades after treatment. Although some risk factors for CRCI are largely immutable (eg, genetics and demographic factors), there are many other contributors to CRCI that when appropriately addressed can result in improved cognitive functioning and quality of life. Neuropsychological assessment can help identify patient cognitive strengths and weaknesses, target psychological and behavioral contributors to CRCI, and guide treatment interventions.

Original languageEnglish (US)
Pages (from-to)1115-1134
Number of pages20
JournalMedical Clinics of North America
Issue number6
StatePublished - Nov 2017


  • Cancer
  • Cancer-related cognitive impairment
  • Chemo brain
  • Chemo fog
  • Cognition
  • Neuropsychological functioning

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Cognitive Changes Related to Cancer Therapy'. Together they form a unique fingerprint.

Cite this